ContextVision AB (publ) (OSL:CONTX)
Norway · Delayed Price · Currency is NOK 3.700
-0.170 (-4.39%)
At close: Jan 13, 2026
ContextVision AB Market Cap
ContextVision AB has a market cap or net worth of 278.63 million as of January 13, 2026. Its market cap has decreased by -37.48% in one year.
Market Cap
278.63M
Enterprise Value
215.98M
Revenue
115.15M
Ranking
n/a
PE Ratio
74.01
Stock Price
3.70
Market Cap Chart
Since March 18, 1997, ContextVision AB's market cap has decreased from 296.00M to 278.63M, a decrease of -5.87%. That is a compound annual growth rate of -0.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 278.63M | -12.74% |
| Dec 30, 2025 | 319.30M | -24.96% |
| Dec 30, 2024 | 425.52M | -28.57% |
| Dec 29, 2023 | 595.73M | -15.75% |
| Dec 30, 2022 | 707.14M | -44.49% |
| Dec 30, 2021 | 1.27B | -25.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.74B |
| Nordhealth AS | 2.83B |
| Photocure ASA | 2.02B |
| Thor Medical ASA | 1.83B |
| ArcticZymes Technologies ASA | 1.25B |
| Omda AS | 982.32M |
| Vistin Pharma ASA | 931.24M |
| Gentian Diagnostics ASA | 894.50M |